Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model

BACKGROUND: Primary cytoreductive surgery followed by adjuvant chemotherapy is the standard treatment for advanced epithelial ovarian cancer. The average interval between surgery and chemotherapy initiation is approximately 4-weeks at most centers; however, since surgery may accelerate residual tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yooyoung, Kollara, Alexandra, May, Taymaa, Brown, Theodore J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032528/
https://www.ncbi.nlm.nih.gov/pubmed/29973223
http://dx.doi.org/10.1186/s13048-018-0428-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032528/
https://www.ncbi.nlm.nih.gov/pubmed/29973223
http://dx.doi.org/10.1186/s13048-018-0428-6

Ejemplares similares